Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
OXIS, which develops, manufactures, and markets products and technologies related to oxidative stress, currently offers more than 80 research products and two specialty compounds, Ergothioneine and Orgotein, for sale. The Company also reported a gross profit for the first quarter of 2003 of $329,000, a 57% increase as compared to $210,000 for the same period in 2002. Rogers added, “During the first quarter, we announced our new Animal Health Profiling program. This significant program was created to bring to market the Company’s oxidative stress screening test for analytical profiling of the health of animals, such as cattle. We believe that we have the industry’s first biomarker relative to cattle health ( www.oxis.com )
OXIS International , Inc.
323 Vintage Park Dr Suite B
Foster City, California 94404-1136
USA
Tel: (650) 212-2568
Fax: (503) 283-4058